- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cipla Limited — Updates, 30-10-2025: Press Release
30-10-2025 | 01:54 pm
30-10-2025 | 01:54 pm
Cipla posted highest-ever Q2FY26 revenue of INR 7,589 Cr (+8% YoY) with 25% EBITDA margin. PAT rose 4% to INR 1,351 Cr. Growth was broad-based across India, North America ($233 Mn revenue, US biosimilar launch), Africa, and Emerging Markets. #Pharma #Q2Results
No comments yet. Be the first to comment!